High fives and sobs greet UnitedHealthcare ’s reversal of denials for gene therapy

Two young children will receive a novel drug to treat spinal muscular atrophy thanks to UnitedHealthcare’s reversal of denials for gene therapy: https://www.washingtonpost.com/business/economy/high-fives-and-sobs-greet-unitedhealthcares-reversal-of-denials-for-child-gene-therapy/2019/07/18/8ddeb3ae-a974-11e9-9214-246e594de5d5_story.html

…

Source: blog.bioethics.net - July 22, 2019 Category: Medical Ethics Authors: Sophie Tags: Uncategorized Source Type: blogs